Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Carcinoma, Non-Small-Cell Lung × lorlatinib × Clear all

Status

Completed 6 Active not recruiting 5 Recruiting 4 Unknown 3 Not yet recruiting 2 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hyperlipidemias 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 2 trilaciclib 1 trastuzumab deruxtecan 1 lorlatinib 1 aumolertinib 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1 Anterior Temporal Lobectomy 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06876675 2025-03-14

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

Peking University Third Hospital

Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Hyperlipidemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡